---
title: "Ascentage Pharma: Revenue up 29%, but net loss widened on higher R&D and selling costs; cash reserves declined"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296409508.md"
description: "Revenue grew 29.3% year-over-year to RMB302.2 million, driven by strong product sales, while net loss widened to RMB817.0 million due to increased R&D and selling expenses. Cash reserves declined as investments in clinical trials and commercialization expanded, with strategic leadership appointments and pipeline progress supporting future growth.Original document: Ascentage Pharma Group International [6855] Earnings Release — Aug. 20 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-19T23:09:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296409508.md)
  - [en](https://longbridge.com/en/news/296409508.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296409508.md)
generator: "portal-rs"
---

# Ascentage Pharma: Revenue up 29%, but net loss widened on higher R&D and selling costs; cash reserves declined

Revenue grew 29.3% year-over-year to RMB302.2 million, driven by strong product sales, while net loss widened to RMB817.0 million due to increased R&D and selling expenses. Cash reserves declined as investments in clinical trials and commercialization expanded, with strategic leadership appointments and pipeline progress supporting future growth.

Original document: Ascentage Pharma Group International \[6855\] Earnings Release — Aug. 20 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [AAPG.US](https://longbridge.com/en/quote/AAPG.US.md)
- [06855.HK](https://longbridge.com/en/quote/06855.HK.md)
- [AAPGV.US](https://longbridge.com/en/quote/AAPGV.US.md)

## Related News & Research

- [Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates | AAPG Stock News](https://longbridge.com/en/news/296408912.md)
- [ASCENTAGE  1H26 Loss Widens to RMB817 million; No Interim Dividend](https://longbridge.com/en/news/296423848.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [AI Winners, Victims, and the One Stock to Sell Now](https://longbridge.com/en/news/297431483.md)
- [How China is building an edge over the US in video AI](https://longbridge.com/en/news/297411806.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**